Ricardo Costa
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Immunology top 10%
- Co-authors
- William J. GradisharHyo S. HanBenedito A. CarneiroFrancis J. GilesBrian J. CzernieckiYoung Kwang ChaeMassimo CristofanilliAparna Kalyan
- Topics
- HER2/EGFR in Cancer Research (19 papers)Cancer Immunotherapy and Biomarkers (17 papers)Advanced Breast Cancer Therapies (16 papers)
- Journals
- Nature MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesBrazilPortugal
In The Last Decade
Ricardo Costa
74 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 1.1k
- Molecular Biology 848
- Pulmonary and Respiratory Medicine 601
- Cancer Research 540
- Immunology 268
Countries citing papers authored by Ricardo Costa
This map shows the geographic impact of Ricardo Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Costa more than expected).
Fields of papers citing papers by Ricardo Costa
This network shows the impact of papers produced by Ricardo Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Costa. The network helps show where Ricardo Costa may publish in the future.
Co-authorship network of co-authors of Ricardo Costa
This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Costa. A scholar is included among the top collaborators of Ricardo Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Costa. Ricardo Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 50 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 13 | |
| 8 | 8 | |
| 9 | 14 | |
| 10 | 62 | |
| 11 | 106 | |
| 12 | 17 | |
| 13 | 16 | |
| 14 | 36 | |
| 15 | Fibroblast Growth Factor Receptor (FGFR) as a Therapeutic Target in Lung and Head and Neck Cancer | 6 |
| 16 | 23 | |
| 17 | 4 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 3 |
About Ricardo Costa
Ricardo Costa is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 2.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (19 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Advanced Breast Cancer Therapies (16 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (540 citations) and Pulmonary and Respiratory Medicine (601 citations). Ricardo Costa has collaborated with scholars based in United States, Brazil and Portugal. Frequent co-authors include William J. Gradishar, Hyo S. Han, Benedito A. Carneiro, Francis J. Giles, Brian J. Czerniecki, Young Kwang Chae, Massimo Cristofanilli, Aparna Kalyan, Alfred Rademaker and Marcelo Cruz. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.